PG
CRL icon

PEAK6 Group’s Charles River Laboratories CRL Stock Holding History

PEAK6 Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$502K Sell
4,469
-8,098
-64% -$875K ﹤0.01% 2590
2018
Q1 		$1.34M Buy
12,567
+1,186
+10% +$128K 0.01% 1694
2017
Q4 		$1.25M Buy
+11,381
New +$1.24M 0.01% 1752
2017
Q3 		– Sell
-3,302
Closed -$334K – 4477
2017
Q2 		$334K Sell
3,302
-6,701
-67% -$617K ﹤0.01% 2891
2017
Q1 		$900K Buy
10,003
+3,595
+56% +$305K 0.01% 1773
2016
Q4 		$488K Buy
+6,408
New +$487K ﹤0.01% 2536
2016
Q3 		– Sell
-8,250
Closed -$692K – 4351
2016
Q2 		$680K Buy
8,250
+2,947
+56% +$243K 0.01% 2120
2016
Q1 		$403K Buy
5,303
+4,417
+499% +$327K ﹤0.01% 2476
2015
Q4 		$71K Sell
886
-10,525
-92% -$759K ﹤0.01% 4130
2015
Q3 		$725K Sell
11,411
-699
-6% -$50.2K ﹤0.01% 2532
2015
Q2 		$852K Buy
+12,110
New +$896K 0.01% 2251
2014
Q2 		– Sell
-30,005
Closed -$1.65M – 4673
2014
Q1 		$1.81M Buy
30,005
+21,847
+268% +$1.27M 0.02% 1344
2013
Q4 		$433K Buy
+8,158
New +$410K ﹤0.01% 2792

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Group's CRL Position: Q2 2018 in Review

PEAK6 Group reduced its Charles River Laboratories (CRL) stake by 64% in Q2 2018, selling an estimated $875K and leaving 4,469 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

PEAK6 Group first reported a position in CRL in Q4 2013 and has held it in 13 quarters since. The position peaked at $1.81M in Q1 2014. 348 funds tracked by Wall St. Rank hold CRL as of Q2 2018.

  • PEAK6 Group held 4,469 shares of Charles River Laboratories worth $502K as of Q2 2018.
  • PEAK6 Group sold 8,098 Charles River Laboratories shares in Q2 2018, an estimated $875K.
  • Charles River Laboratories made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2590 holding.
  • PEAK6 Group first reported a position in Charles River Laboratories in Q4 2013 and has held it in 13 quarters since.
  • PEAK6 Group's Charles River Laboratories position peaked at $1.81M in Q1 2014.
  • 348 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.